Literature DB >> 27745834

RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population.

Sirui Zhou1, Amirthagowri Ambalavanan2, Daniel Rochefort3, Pingxing Xie4, Cynthia V Bourassa3, Pascale Hince3, Alexandre Dionne-Laporte3, Dan Spiegelman3, Ziv Gan-Or5, Cathy Mirarchi3, Vessela Zaharieva3, Nicolas Dupré6, Hatasu Kobayashi7, Toshiaki Hitomi7, Kouji Harada7, Akio Koizumi7, Lan Xiong8, Patrick A Dion9, Guy A Rouleau10.   

Abstract

Intracranial aneurysms (IAs) are the result of focal weakness in the artery wall and have a complex genetic makeup. To date, genome-wide association and sequencing studies have had limited success in identifying IA risk factors. Distinct populations, such as the French-Canadian (FC) population, have increased IA prevalence. In our study, we used exome sequencing to prioritize risk variants in a discovery cohort of six FC families affected by IA, and the analysis revealed an increased variation burden for ring finger protein 213 (RNF213). We resequenced RNF213 in a larger FC validation cohort, and association tests on further identified variants supported our findings (SKAT-O, p = 0.006). RNF213 belongs to the AAA+ protein family, and two variants (p.Arg2438Cys and p.Ala2826Thr) unique to affected FC individuals were found to have increased ATPase activity, which could lead to increased risk of IA by elevating angiogenic activities. Common SNPs in RNF213 were also extracted from the NeuroX SNP-chip genotype data, comprising 257 FC IA-affected and 1,988 control individuals. We discovered that the non-ancestral allele of rs6565666 was significantly associated with the affected individuals (p = 0.03), and it appeared as though the frequency of the risk allele had changed through genetic drift. Although RNF213 is a risk factor for moyamoya disease in East Asians, we demonstrated that it might also be a risk factor for IA in the FC population. It therefore appears that the function of RNF213 can be differently altered to predispose distinct populations to dissimilar neurovascular conditions, highlighting the importance of a population's background in genetic studies of heterogeneous disease.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27745834      PMCID: PMC5097946          DOI: 10.1016/j.ajhg.2016.09.001

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  74 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.

Authors:  Toshiaki Hitomi; Toshiyuki Habu; Hatasu Kobayashi; Hiroko Okuda; Kouji H Harada; Kenji Osafune; Daisuke Taura; Masakatsu Sone; Isao Asaka; Tomonaga Ameku; Akira Watanabe; Tomoko Kasahara; Tomomi Sudo; Fumihiko Shiota; Hirokuni Hashikata; Yasushi Takagi; Daisuke Morito; Susumu Miyamoto; Kazuwa Nakao; Akio Koizumi
Journal:  Biochem Biophys Res Commun       Date:  2013-07-12       Impact factor: 3.575

3.  Identification of a novel RNF213 variant in a family with heterogeneous intracerebral vasculopathy.

Authors:  Katherine R Smith; Richard J Leventer; Mark T Mackay; Kate Pope; Greta Gillies; Martin B Delatycki; David J Amor; Melanie Bahlo; Paul J Lockhart
Journal:  Int J Stroke       Date:  2014-08       Impact factor: 5.266

4.  Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease.

Authors:  Akira Ito; Miki Fujimura; Kuniyasu Niizuma; Atsushi Kanoke; Hiroyuki Sakata; Yuiko Morita-Fujimura; Atsuo Kikuchi; Shigeo Kure; Teiji Tominaga
Journal:  Brain Res       Date:  2014-11-13       Impact factor: 3.252

5.  Epidemiological study of reptured intracranial aneurysms in the Saguenay-Lac-Saint-Jean region (Quebec, Canada).

Authors:  J Mathieu; L Pérusse; P Allard; C Prévost; L Cantin; J M Bouchard; M DeBraekeleer
Journal:  Can J Neurol Sci       Date:  1996-08       Impact factor: 2.104

6.  Intracranial aneurysms: a report of a large pedigree.

Authors:  F Halal; G Mohr; T Toussi; S Napoléon Martinez
Journal:  Am J Med Genet       Date:  1983-05

7.  Risk factors for subarachnoid hemorrhage: a systematic review.

Authors:  L L Teunissen; G J Rinkel; A Algra; J van Gijn
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

8.  Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.

Authors:  Satoru Miyawaki; Hideaki Imai; Masahiro Shimizu; Shinichi Yagi; Hideaki Ono; Akitake Mukasa; Hirofumi Nakatomi; Tsuneo Shimizu; Nobuhito Saito
Journal:  Stroke       Date:  2013-08-22       Impact factor: 7.914

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.

Authors:  Lorelei D Shoemaker; Michael J Clark; Anil Patwardhan; Gemma Chandratillake; Sarah Garcia; Rong Chen; Alexander A Morgan; Nan Leng; Scott Kirk; Richard Chen; Douglas J Cook; Michael Snyder; Gary K Steinberg
Journal:  G3 (Bethesda)       Date:  2015-11-03       Impact factor: 3.542

View more
  24 in total

1.  Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.

Authors:  Stéphanie Guey; Markus Kraemer; Dominique Hervé; Thomas Ludwig; Manoëlle Kossorotoff; Françoise Bergametti; Jan Claudius Schwitalla; Simone Choi; Lucile Broseus; Isabelle Callebaut; Emmanuelle Genin; Elisabeth Tournier-Lasserve
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

2.  Rare Coding Variants in ANGPTL6 Are Associated with Familial Forms of Intracranial Aneurysm.

Authors:  Romain Bourcier; Solena Le Scouarnec; Stéphanie Bonnaud; Matilde Karakachoff; Emmanuelle Bourcereau; Sandrine Heurtebise-Chrétien; Céline Menguy; Christian Dina; Floriane Simonet; Alexis Moles; Cédric Lenoble; Pierre Lindenbaum; Stéphanie Chatel; Bertrand Isidor; Emmanuelle Génin; Jean-François Deleuze; Jean-Jacques Schott; Hervé Le Marec; Gervaise Loirand; Hubert Desal; Richard Redon
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

3.  Pericyte Ontogeny: The Use of Chimeras to Track a Cell Lineage of Diverse Germ Line Origins.

Authors:  Heather C Etchevers
Journal:  Methods Mol Biol       Date:  2021

4.  Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish.

Authors:  Jing Lin; Jie Liang; Jun Wen; Man Luo; Jiaoxing Li; Xunsha Sun; Xiaowei Xu; Jianli Li; Dongxian Wang; Jie Wang; Huimin Chen; Rong Lai; Fengyin Liang; Chuan Li; Fei Ye; Jingjing Zhang; Jinsheng Zeng; Shulan Yang; Wenli Sheng
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-04       Impact factor: 6.200

5.  Exome sequencing reveals a novel variant in NFX1 causing intracranial aneurysm in a Chinese family.

Authors:  Xinghuan Ding; Sen Zhao; Qianqian Zhang; Zihui Yan; Yang Wang; Yong Wu; Xiaoxin Li; Jian Liu; Yuchen Niu; Yisen Zhang; Mingqi Zhang; Huizi Wang; Ying Zhang; Weisheng Chen; Xin-Zhuang Yang; Pengfei Liu; Jennifer E Posey; James R Lupski; Zhihong Wu; Xinjian Yang; Nan Wu; Kun Wang
Journal:  J Neurointerv Surg       Date:  2019-08-10       Impact factor: 5.836

6.  Genetic architecture and adaptations of Nunavik Inuit.

Authors:  Sirui Zhou; Pingxing Xie; Amélie Quoibion; Amirthagowri Ambalavanan; Alexandre Dionne-Laporte; Dan Spiegelman; Cynthia V Bourassa; Lan Xiong; Patrick A Dion; Guy A Rouleau
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-22       Impact factor: 11.205

7.  Activated leukocyte cell adhesion molecule/cluster of differentiation 166 rs10933819 (G>A) variant is associated with familial intracranial aneurysms.

Authors:  Akbota Aitkulova; Kymbat Mukhtarova; Elena Zholdybayeva; Yerkin Medetov; Botagoz Dzhamantayeva; Kuat Kassymbek; Talgat Utupov; Ilyas Akhmetollayev; Serik Akshulakov; Gulmira Kulmambetova; Yerlan Ramankulov
Journal:  Biomed Rep       Date:  2022-06-07

8.  PPIL4 is essential for brain angiogenesis and implicated in intracranial aneurysms in humans.

Authors:  Tanyeri Barak; Emma Ristori; A Gulhan Ercan-Sencicek; Danielle F Miyagishima; Carol Nelson-Williams; Weilai Dong; Sheng Chih Jin; Andrew Prendergast; William Armero; Octavian Henegariu; E Zeynep Erson-Omay; Akdes Serin Harmancı; Mikhael Guy; Batur Gültekin; Deniz Kilic; Devendra K Rai; Nükte Goc; Stephanie Marie Aguilera; Burcu Gülez; Selin Altinok; Kent Ozcan; Yanki Yarman; Süleyman Coskun; Emily Sempou; Engin Deniz; Jared Hintzen; Andrew Cox; Elena Fomchenko; Su Woong Jung; Ali Kemal Ozturk; Angeliki Louvi; Kaya Bilgüvar; E Sander Connolly; Mustafa K Khokha; Kristopher T Kahle; Katsuhito Yasuno; Richard P Lifton; Ketu Mishra-Gorur; Stefania Nicoli; Murat Günel
Journal:  Nat Med       Date:  2021-12-09       Impact factor: 87.241

9.  Rho Guanine Nucleotide Exchange Factor ARHGEF17 Is a Risk Gene for Intracranial Aneurysms.

Authors:  Xinyu Yang; Jiani Li; Yabo Fang; Zhen Zhang; Daqing Jin; Xingdong Chen; Yan Zhao; Mengqi Li; Linchun Huan; Thomas A Kent; Jing-Fei Dong; Rongcai Jiang; Shuyuan Yang; Li Jin; Jianning Zhang; Tao P Zhong; Fuli Yu
Journal:  Circ Genom Precis Med       Date:  2018-07

10.  Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China.

Authors:  Fei Ye; Tianzhu Wang; Haoyuan Yin; Jiaoxing Li; Haiyan Li; Tongli Guo; Xiong Zhang; Tingting Yang; Liang Jie; Xiaoxin Wu; Qi Li; Wenli Sheng
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.